Effects of nucleosomes and anti-tumor drugs on the catalytic activity of type II DNA topoisomerase from rat testis

Biochemical Pharmacology

Volumn 53, Issue 9, 1997, Pages 1229-1238

  Galande, Sanjeev ^a   Muniyappa, K ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Anti tumor drugs; Histone H1; Nucleosomes; Topoisomerases; Unwinding

Indexed keywords

AMILORIDE; AMSACRINE; DNA TOPOISOMERASE (ATP HYDROLYSING); HISTONE H1; TENIPOSIDE;

ANIMAL TISSUE; ARTICLE; DNA DENATURATION; DOSE RESPONSE; DRUG EFFECT; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; MALE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; RAT; TESTIS;

ANIMALS; ANTINEOPLASTIC AGENTS; BACTERIOPHAGE M13; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DNA, VIRAL; LIVER; MALE; NUCLEIC ACID CONFORMATION; NUCLEOSOMES; RATS; TENIPOSIDE; TESTIS;

EID: 0030750571     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00897-0     Document Type: Article

References (49)

1. Wang JC, DNA topoisomerases. Annu Rev Biochem 54: 665-697, 1985.
2. Watt PM and Hickson ID, Structure and function of type II DNA topoisomerases. Biochem J 303: 681-695, 1994.
3. Maxwell A and Gellert M, Mechanistic aspects of DNA topoisomerases. Adv Protein Chem 38: 69-107, 1986.
4. Sternglanz R, DNA topoisomerases. Curr Opin Cell Biol 1: 533-535, 1989.
5. Earnshaw WC and Heck MM, Localization of topoisomerase II in mitotic chromosomes. J Cell Biol 100: 1716-1725, 1985.
6. Gasser SM, Laroche T, Falquet J, Boy de la Tour E and Laemmli UK, Metaphase chromosome structure: Involvement of topoisomerase II. J Mol Biol 188: 613-629, 1986.
7. Adachi Y, Kas E and Laemmli UK, Preferential, cooperative binding of DNA topoisomerase II to scaffold-associated regions. EMBO J 8: 3997-4006, 1989.
8. Kas E, Izaurralde E and Laemmli UK, Specific inhibition of DNA binding to nuclear scaffolds and histone H1 by distamycin. J Mol Biol 210: 587-599, 1989.
9. Zechiedrich EL and Osheroff N, Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossovers. EMBO J 9: 4555-4562, 1990.
10. Roca J, Berger JM and Wang J, On the simultaneous binding of eukaryotic topoisomerase II to a pair of double-stranded DNA helices. J Biol Chem 268: 14250-14255, 1993.
11. Roca J, and Wang JC, DNA transport by a type II DNA topoisomerase: Evidence in favor of a two-gate mechanism. Cell 77: 609-616, 1994.
12. Lindsley JE and Wang JC, Proteolysis patterns of epitopically labeled yeast DNA topoisomerase II suggest an allosteric transition in the enzyme induced by ATP binding. Proc Natl Acad Sci USA 88: 10485-10489, 1991.
13. Osheroff N, Zechiedrich EL and Gale KC, Catalytic functions of DNA topoisomerase II. Bioessays 13: 269-275, 1991.
14. Ross WE, DNA topoisomerases as targets for cancer therapy. Biochem Pharmacol 34: 4191-4195, 1985.
15. Liu LF, DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58: 351-375, 1989.
16. Corbett AH and Osheroff N, When good enzymes go bad: Conversion of topoisomerase II to a cellular toxin by anti-neoplastic drugs. Chem Res Toxicol 6: 584-597, 1993.
17. Vassetzky YS, Alghisi G-C and Gasser SM, DNA topoisomerase II mutations and resistance to anti-tumor drugs. Bioessays 17: 767-774, 1995.
18. Roca J, Ishida R, Berger JM, Andoh T and Wang JC, Anti-tumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed clamp. Proc Natl Acad Sci USA 91: 1781-1785, 1994.
19. Wolffe A, Chromatin: Structure and Function. Academic Press, New York, 1992.
20. Morse RH, Changes in the pattern of histone binding to DNA upon transcriptional activation. Trends Biochem Sci 17: 23-26, 1992.
21. Tsukiyama T, Becker PB and Wu C, ATP-dependent nucleosome disruption at a heat-shock promoter mediated by binding of GAGA transcription factor. Nature 367: 525-532, 1994.
22. Pina B, Bruggmeier U and Beato M, Nucleosome positioning modulates accessibility of regulatory proteins to the mouse mammary tumor virus promoter. Cell 60: 719-731, 1990.
23. Udvardy A and Schedl P, Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo. Mol Cell Biol 11: 4973-4984, 1991.
24. Galande S and Muniyappa K, Purification and functional characterization of type II DNA topoisomerase from rat testis and comparison with topoisomerase II from liver. Biochim Biophys Acta 1308: 58-66, 1996.
25. Ramdas J, Mythili E and Muniyappa K, Nucleosomes on linear duplex DNA allow homologous pairing but prevent strand exchange promoted by RecA protein. Proc Natl Acad Sci USA 88: 1344-1348, 1991.
26. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
27. Cunningham RP, DasGupta C, Shibata T and Radding CM, Homologous pairing in genetic recombination: RecA protein makes joint molecules of gapped circular DNA and closed circular DNA. Cell 20: 223-235, 1980.
28. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
29. Camerini-Otero RD, Sollner-Webb B and Felsenfeld G, The organization of histones and DNA in chromatin: Evidence for an arginine-rich histone kernel. Cell 8: 333-347, 1976.
30. Clark D and Felsenfeld G, Formation of nucleosomes on positively supercoiled DNA. EMBO J 10: 387-395, 1991.
31. Getts RC and Behe MJ, Eukaryotic DNA does not form nucleosomes as readily as some prokaryotic DNA. Nucleic Acids Res 21: 5923-5927, 1991.
32. Ohba R, Tabuchi H and Hirose S, DNA supercoiling facilitates the assembly of transcriptionally active chromatin on the adenovirus major late promoter. Biochem Biophys Res Commun 186: 963-969, 1992.
33. Garner MM, Felsenfeld G, O'Dea MH and Gellert M, Effects of DNA supercoiling on the topological properties of nucleosomes. Proc Natl Acad Sci USA 84: 2620-2623, 1987.
34. Meistrich ML, Nuclear morphogenesis during spermiogenesis. In: Molecular Biology of the Male Reproductive System (Ed. de Kretser D), pp. 67-97. Academic Press, New York, 1993.
35. Ward SW and Coffey DS, DNA packaging and organization in mammalian spermatozoa: Comparison with somatic cells. Biol Reprod 44: 569-574, 1991.
36. van Wezenbeek PMGF, Hulsebos TJM and Schoenmakers JGG, Nucleotide sequence of the filamentous bacteriophage M13 DNA genome: Comparison with phage fd. Gene 11: 129-148, 1980.
37. Been MD, Burgess RR and Champoux J, Nucleotide sequence preference at rat liver and wheat germ type 1 topoisomerases breakage sites in duplex SV40 DNA. Nucleic Acids Res 12: 3097-3114, 1984.
38. Spitzner JR and Muller MT, A consensus sequence for cleavage by vertebrate topoisomerases II. Nucleic Acids Res 16: 5533-5546, 1988.
39. Spitzner JR, Chung IK and Muller MT, Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats. Nucleic Acids Res 18: 1-11, 1990.
40. Rowe TC, Rusche JR, Brougham MJ and Holloman WR, Purification and properties of topoisomerase from Ustilago maydis. J Biol Chem 256: 10354-10356, 1981.
41. Weinberger GF and Nieschlag E, Hormonal control of spermatogenesis. In: Molecular Biology of the Male Reproductive System (Ed. de Kretser D), P. 99-142. Academic Press, New York, 1993.
42. Capranico G, Jaxel C, Roberge M, Kohn KW and Pommier Y, Nucleosome positioning as a critical determinant for the DNA cleavage of mammalian DNA topoisomerase II in reconstituted simian virus 40 chromatin. Nucleic Acids Res 18: 4553-4559, 1990.
43. Cullinan EB and Beerman TA, A study of drug-induced topoisomerase II-mediated DNA lesions on episomal chromatin. J Biol Chem 264: 16268-16275, 1989.
44. Woynarowski JM, McHugh M, Sigmund RD and Beerman TA, Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4′,6-diamidine-2-phenylindole. Mol Pharmacol 35: 177-182, 1989.
45. Fesen M and Pommier Y, Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA. J Biol Chem 264: 11354-11359, 1989.
46. Richter A and Ruff J, DNA topoisomerase I cleavage sites in DNA and in nucleoprotein complexes. Biochemistry 30: 9741-9748, 1991.
47. Heck MM, Hittelman WN and Earnshaw WC, In vivo phosphorylation of the 170 kDa form of eukaryotic topoisomerase II. J Biol Chem 264: 15161-15164, 1989.
48. Saijo M, Ui M and Enomoto T, Purification and characterization of type II DNA topoisomerase from mouse FM3A cells: Phosphorylation of topoisomerase and modification of its activity. Biochemistry 31: 359-363, 1992.
49. Froelich-Ammon SJ and Osheroff N, Topoisomerase poisons: Harnessing the dark side of enzyme mechanisms. J Biol Chem 270: 21429-21432, 1995.